Myriad Genetics (MYGN) Retained Earnings (2010 - 2026)
Myriad Genetics (MYGN) reported Retained Earnings of -$1.2 billion for Q1 2026, down 192700.0% year-over-year from N/an in Q1 2025, and down 3.04% quarter-over-quarter from -$1.1 billion in Q4 2025.
Myriad Genetics (MYGN) Retained Earnings (2010 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has 17 years of Retained Earnings data on file, last reported at -$1.2 billion in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$1.2 billion, down 192700.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 192700.0% YoY), and the FY2025 annual result was -$1.1 billion, down 140237.5% from the prior year.
- Retained Earnings eased to -$1.2 billion in Q1 2026 per MYGN's latest filing, from -$1.1 billion in the prior quarter.
- Over five years, Retained Earnings peaked at -$100000.0 in Q3 2024 and troughed at -$1.2 billion in Q1 2026.
- A 5-year average of -$344.4 million and a median of -$8.9 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2026: Retained Earnings soared 99.98% in 2024, then slumped 192700.0% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$366.2 million in 2022, then plunged by 71.9% to -$629.5 million in 2023, then jumped by 99.87% to -$800000.0 in 2024, then tumbled by 140237.5% to -$1.1 billion in 2025, then retreated by 3.04% to -$1.2 billion in 2026.
- Business Quant data shows MYGN's Retained Earnings at -$1.2 billion in Q1 2026, -$1.1 billion in Q4 2025, and -$100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -168.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 60.63 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -593.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -64.94 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -202.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -2.86 Bn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -968.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -258.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -344.64 Mn |
| 10 | Myriad Genetics | 424.93 Mn | 300.53 Mn | 137.60 Mn | -1.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.16 Bn |
| Dec 31, 2025 | -1.12 Bn |
| Sep 30, 2025 | -100,000.00 |
| Jun 30, 2025 | -1.09 Bn |
| Mar 31, 2025 | -600,000.00 |
| Dec 31, 2024 | -800,000.00 |
| Sep 30, 2024 | -100,000.00 |
| Jun 30, 2024 | -4.00 Mn |
| Mar 31, 2024 | -4.20 Mn |
| Dec 31, 2023 | -629.50 Mn |
| Sep 30, 2023 | -598.30 Mn |
| Jun 30, 2023 | -537.00 Mn |
| Mar 31, 2023 | -7.40 Mn |
| Dec 31, 2022 | -366.20 Mn |
| Sep 30, 2022 | -323.90 Mn |
| Jun 30, 2022 | -8.90 Mn |
| Mar 31, 2022 | -7.60 Mn |
| Dec 31, 2021 | -254.20 Mn |
| Sep 30, 2021 | -246.60 Mn |
| Jun 30, 2021 | -271.20 Mn |